Clinical trials
Enrolling by invitation Phase 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 9 |
| 2024 | 13 |
| 2025 | 12 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbisko Therapeutics Co, Ltd | 2 |
| Beijing Chest Hospital | 2 |
| Guangdong Second Provincial General Hospital | 2 |
| Haisco Pharmaceutical Group Co., Ltd. | 2 |
| Peking Union Medical College Hospital | 2 |
| Peking University | 2 |
| Sanofi | 2 |
| Sun Yat-sen University | 2 |
| Tianjin Medical University Cancer Institute and Hospital | 2 |
| Yingjuan Zheng | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Neoplasms | 3 |
| Asthma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
| Cholangiocarcinoma | 2 |
| Mycobacterium Infections, Nontuberculous | 2 |
| Small Cell Lung Carcinoma | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Arthritis, Rheumatoid | 1 |
| Breast Carcinoma In Situ | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.